Paper
Botulinum toxin treatment in patients with facial synkinesis.
Published Dec 1, 1994 · R. Laskawi, W. Damenz, P. Roggenkämper
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
22
Citations
0
Influential Citations
Abstract
Botulinum toxin therapy (BTT), originally applied to treat strabism (for review see [8]), is now established as a minimally invasive, successful therapy in a number of diseases. The treatment of mass movements (synkinesis) following paralysis of the facial nerve, which may have various etiologies, has recently been reported as another indication. First experiences with BTT, applied to several patients with such synkinesis, were published by Roggenkamper et al. [7]. This indication was also confirmed by case reports by other authors [2, 6]. According to Roggenkamper et al. [7] this treatment is effective for an average of 11 weeks after the first injection, according to patients’ personal assessment.
Full text analysis coming soon...